Randomized controlled trials have shown that implantable cardioverter defibrillator (ICD) therapy improves survival in appropriately selected patients with left ventricular dysfunction due to myocardial infarction (MI). Specific recommendations for ICD therapy have been included in consensus guidelines. There is, however, uncertainty as to whether guidelines on prophylactic ICD therapy are being applied in "real world" clinical practice. A report from a tertiary care center in Israel shows that in the period between 2005 and 2009, a prophylactic ICD was implanted in only 14% of post-MI patients in whom it was indicated, according to current guidelines. Importantly, failure to systematically reassess left ventricular function after a MI was linked to underuse of ICDs. Various factors such as differential coverage by health care insurances, patients' decision, physician's evaluation of co-morbidities and age, as well as under-referral to specialized centers may be involved in limiting the use of prophylactic ICDs. The shortfall in ICD implant rate in relation to that expected from current guidelines calls for further integration of healthcare systems.

Prophylactic cardioverter defibrillator utilization in the "real world": a conundrum / Boriani, Giuseppe; Leyva, F.. - In: INTERNATIONAL JOURNAL OF CARDIOLOGY. - ISSN 0167-5273. - 156:(2012), pp. 123-124. [10.1016/j.ijcard.2011.10.018]

Prophylactic cardioverter defibrillator utilization in the "real world": a conundrum.

BORIANI, Giuseppe;
2012

Abstract

Randomized controlled trials have shown that implantable cardioverter defibrillator (ICD) therapy improves survival in appropriately selected patients with left ventricular dysfunction due to myocardial infarction (MI). Specific recommendations for ICD therapy have been included in consensus guidelines. There is, however, uncertainty as to whether guidelines on prophylactic ICD therapy are being applied in "real world" clinical practice. A report from a tertiary care center in Israel shows that in the period between 2005 and 2009, a prophylactic ICD was implanted in only 14% of post-MI patients in whom it was indicated, according to current guidelines. Importantly, failure to systematically reassess left ventricular function after a MI was linked to underuse of ICDs. Various factors such as differential coverage by health care insurances, patients' decision, physician's evaluation of co-morbidities and age, as well as under-referral to specialized centers may be involved in limiting the use of prophylactic ICDs. The shortfall in ICD implant rate in relation to that expected from current guidelines calls for further integration of healthcare systems.
2012
156
123
124
Prophylactic cardioverter defibrillator utilization in the "real world": a conundrum / Boriani, Giuseppe; Leyva, F.. - In: INTERNATIONAL JOURNAL OF CARDIOLOGY. - ISSN 0167-5273. - 156:(2012), pp. 123-124. [10.1016/j.ijcard.2011.10.018]
Boriani, Giuseppe; Leyva, F.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1080232
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 2
social impact